A GIS‐based decision‐making approach for prioritizing seabird management following predator eradication

Given that 29% of seabird species are threatened with extinction, protecting seabird colonies on offshore islands is a global conservation priority. Seabirds are vulnerable to non‐native predator invasions, which reduce or eliminate colonies. Accordingly, conservation efforts have focused on predator eradication. However, affected populations are often left to passively recover following eradications. Although seabirds are highly mobile, their life history traits such as philopatry can limit passive recolonization of newly predator‐free habitat. In such cases, seabird colonies can potentially be re‐instated with active restoration via chick translocations or social attraction methods, which can be risky and expensive. We used biogeographic and species‐specific behavioral data in the Hauraki Gulf, New Zealand, a global hotspot of seabird diversity and predator eradications, to illustrate the use of geographic information systems multi‐criteria decision analysis to prioritize islands for active seabird restoration. We identified nine islands with low observed passive recovery of seabirds posteradication over a 50‐year timeframe, and classified these as sites where active seabird management could be prioritized. Such spatially explicit tools are flexible, allowing for managers to choose case‐specific criteria such as time, funding, and goals constrained for their conservation needs. Furthermore, this flexibility can also be applied to threatened species management by customizing the decision criteria for individual species' capacity to passively recolonize islands. On islands with complex restoration challenges, decision tools that help island restoration practitioners decide whether active seabird management should be paired with eradication can optimize restoration outcomes and ecosystem recovery.     

Emodepside and SL0-1 potassium channels: a review

Nematode parasites infect humans and domestic animals; treatment and prophylaxis require anthelmintic drugs because vaccination and sanitation is limited. Emodepside is a more recently introduced cyclooctadepsipeptide drug that has actions against GI nematodes, lungworm, and microfilaria. It has a novel mode of action which breaks resistance to the classical anthelmintics (benzimidazoles, macrocyclic lactones and cholinergic agonists). Here we review studies on its mode of action which suggest that it acts to inhibit neuronal and muscle activity of nematodes by increasing the opening of calcium-activated potassium (SLO-1) channels.     

Purification and characterization of two phage PBSX-induced lytic enzymes of Bacillus subtilis 168: an N-acetylmuramoyl-L-alanine amidase and an N-acetylmuramidase

After heat-induction of the defective phage PBSX in a xhi-1479 mutant of Bacillus subtilis 168, the culture lysed rapidly even if the lyt-2 mutation was present (which greatly reduces the amount of the bacterial autolysins). Two lytic enzymes, an N-acetylmuramoyl-L-alanine amidase and an endo-N-acetylmuramidase, were purified from the culture supernatant. The amidase was readily distinguished from the bacterial amidase by its low molecular weight. In addition, it was not inhibited by antibody directed against the bacterial enzyme. These results indicate that PBSX does not rely on the bacterial autolysins to accomplish lysis.     

The biology of the panga, Pterogymnus laniarius (Teleostei: Sparidae), on the Agulhas Bank, South Africa

Aspects of the biology of the panga, Pterogymnus laniarius, a commercially important endemic southern African, demersal sparid fish species, are described from material collected monthly between February 1994 and July 1995 on the Agulhas Bank, South Africa. Growth studies based on sectioned sagittal otoliths revealed that the panga is relatively slow growing with ages of 16 years being recorded. Growth was best described by the von Bertalanffy growth model as L_t = 379.4 (1-e^{–0.13(t+1.78)}). Estimates of total mortality, natural and fishing mortality were estimated at 0.36 year^–1 0.28 year^–1 and 0.08 year^–1, respectively. Detailed histological examination revealed that panga are late gonochorists, males and females maturing after a non-functional intersexual interval. Females mature at approximately 200 mm fork length or 4 years of age. Reproductive activity occurs throughout the year, peaking slightly in winter when small pelagic eggs are spawned. Gametogenesis was found to be similar to that of other sparid fishes and marine teleosts in general. The panga feeds predominantly on crustaceans with a distinct ontogenetic shift in feeding habits. Juvenile fish feed predominantly in the water column on mysids after which they move to the benthos with subadult fish feeding on ophiuroids and amphipods. Adult fish remain on or near the benthos, feeding predominantly on crabs with polychaetes, ophiuroids and fishes also present in the diet in smaller quantities. Several aspects of the panga's biology such as it's late gonochoristic reproductive style, protracted spawning season, maturation before recruitment and the ability to utilise large areas of the Agulhas Bank by feeding on soft substratum prey are thought to enable this species to sustain a higher fishing pressure than other sympatric sparid species. The panga's longevity, slow growth and high natural mortality rate mitigates against these factors and needs to be considered in the development of a management strategy.     

The human gene (DSG2) coding for HDGC, a second member of the desmoglein subfamily of the desmosomal cadherins, is, like DSG1 coding for desmoglein DGI, assigned to chromosome 18.

Desmoglein is a transmembrane glycoprotein of the cadherin superfamily present in the desmosomal junction in vertebrate epithelial cells. At least two variants of desmoglein are differentially expressed in human tissues: DGI, a characteristic desmosomal protein; and HDGC, which is, for example, expressed in the simple epithelium of the colon. Using a PCR assay, we were able to assign DSG2, the gene coding for desmoglein HDGC, to chromosome 18, the same chromosomal localization to which we have previously assigned DSG1 coding for desmoglein DGI.     

Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian setting

Background:

Although injection drug use is known to result in a range of health-related harms, including transmission of HIV and fatal overdose, little is known about the possible role of synthetic drugs in injection initiation. We sought to determine the effect of crystal methamphetamine use on risk of injection initiation among street-involved youth in a Canadian setting.

Methods:

We used Cox regression analyses to identify predictors of injection initiation among injection-naive street-involved youth enrolled in the At-Risk Youth Study, a prospective cohort study of street-involved youth in Vancouver, British Columbia. Data on circumstances of first injection were also obtained.

Results:

Between October 2005 and November 2010, a total of 395 drug injection–naive, street-involved youth provided 1434 observations, with 64 (16.2%) participants initiating injection drug use during the follow-up period, for a cumulative incidence of 21.7 (95% confidence interval [CI] 1.7–41.7) per 100 person-years. In multivariable analysis, recent noninjection use of crystal methamphetamine was positively associated with subsequent injection initiation (adjusted hazard ratio 1.93, 95% CI 1.31–2.85). The drug of first injection was most commonly reported as crystal methamphetamine (14/31 [45%]).

Interpretation:

Noninjection use of crystal methamphetamine predicted subsequent injection initiation, and crystal methamphetamine was the most commonly used drug at the time of first injection. Evidence-based strategies to prevent transition to injection drug use among crystal methamphetamine users are urgently needed.Street-involved youth are at high risk of initiating injection drug use.¹ This situation is of concern, given that injection drug use has been associated with increased risk of transmission of HIV and hepatitis C virus^2,3 and fatal overdose,⁴ as well as a range of other serious negative health and social outcomes. Newly initiated injection drug users have also been identified as a subpopulation at particularly high risk of injection-related harm.^5–8 Unfortunately, despite recent calls to prioritize interventions to prevent the initiation of injection drug use,⁹ there are few evidence-based strategies to prevent injection initiation among street-involved youth.This situation relates, in part, to the fact that little is known about the risk factors for injection initiation within this population. Prospective research from Montréal, Quebec, has alluded to the role that crack and powder cocaine may play in promoting subsequent injection initiation,¹⁰ as has retrospective research conducted among drug users in Baltimore, Maryland.¹¹ Much less is known about the possible role that synthetic drugs, such as methamphetamine, may play in contributing to an increased risk of injection initiation.¹² Globally, amphetamine-type stimulants have emerged as one of the most commonly used groups of illicit drugs, second only to cannabis.¹³ This increase in amphetamine use is reflected in the epidemiology of drug use in some Canadian settings. For instance, in Vancouver, British Columbia, rates of injection use of crystal methamphetamine have increased significantly among adult injection drug users.¹⁴ This pattern is of substantial public health concern, given that crystal methamphetamine has been associated with a range of health and social harms, including the potential to drive high-risk drug-use patterns, including injection.¹⁵ Given these concerns and the well-established health-related harms of injection drug use, we investigated the possible role of crystal methamphetamine use in the incidence of first injection drug use within a cohort of street-involved youth in a Canadian setting.     

Enhancement of adenylate cyclase activity in S49 lymphoma cells by phorbol esters. Putative effect of C kinase on alpha s-GTP-catalytic subunit interaction

Addition of 12-O-tetradecanoylphorbol-13-acetate (TPA) to S49 lymphoma cells (wild type and a cyclic AMP-dependent protein kinase-lacking clone) has little effect alone but doubles accumulation of cyclic AMP in response to isoproterenol. The effect is immediate and has an apparent affinity and order of potency characteristic of the activation of protein kinase C by phorbol esters. Enhancement does not reflect an altered time course of the beta-adrenergic response, enhanced affinity of the cellular beta-receptor for agonist, or decreased degradation and export of cellular cyclic AMP. Reduction of the beta-adrenergic response by somatostatin does not remove the effect of TPA nor does TPA abolish the effect of somatostatin. Phorbol ester enhances cyclic AMP accumulation in response to cholera toxin in wild type and UNC clones but not in H21a or cyc-. TPA also enhances cAMP accumulation in response to forskolin in wild type cells. The effect of TPA is stable to rapid preparation of membranes. In adenylate cyclase assays on membranes from cells treated with TPA, the activation by guanosine 5'-(beta, gamma-imino)triphosphate is enhanced by 40% with no change in lag time; the effect of beta-agonist plus Gpp(NH)p is similarly enhanced; activation by Mn2+ is unchanged. We conclude that phorbol ester facilitates the productive interaction of the alpha subunit of the transducer protein Gs with the catalytic unit of adenylate cyclase, hypothetically via an action of protein kinase C.